| Name | Title | Contact Details |
|---|
Maxim Healthcare Services is a healthcare staffing agency that provides recruitment, training, and management of a diverse healthcare workforce for their clients.
Apervita is the trusted healthcare collaboration platform for quality measurement, clinical intelligence, value optimization and interoperability. We empower payers and providers and other stakeholders to more efficiently and effectively measure clinical and financial performance, improve clinical quality and administer and run analytics on value-based contracts. By providing an independent, secure, trusted platform to perform shared analyses, Apervita uniquely allows stakeholders to gain mutual, continuous clinical and financial insights and integrate those insights in various systems and workflows simultaneously and at scale. Serving more than one in three hospitals in the United States and several nationally recognized health plans, Apervita conducts more than 10 billion value-based computations and insights for our clients every year. Serving more than one in five hospitals in the United States and several nationally recognized health plans, Apervita conducts more than 1 billion value-based computations and insights for our clients every year. Founded in 2012, the company maintains office locations in Chicago and Boston.
Affymetrix/USB Corporation is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
VASAMED, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Eden Prairie, MN. To find more information about VASAMED, Inc., please visit www.vasamed.com
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare diseases. Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in Limb-girdle muscular dystrophy (LGMD), Charcot-Marie-Tooth (CMT) and CNS-related disorders, reaching a total of over 20 therapies in various stages of development. The Company`s programs span across several therapeutic modalities, including RNA, gene therapy and gene editing. Sarepta is poised to be the most meaningful precision genetic medicine company in the world and make a profound difference in the lives of patients suffering from rare neuromuscular diseases and other rare diseases.